Morpholino People

Morpholino People, LLC is a consulting company focused on helping organizations develop and grow in the Morpholino oligonucleotide market. Drawing on 24 years of experience in the Morpholino industry, the company supports clients with oligo design, staff training, marketing, and customer education. Its work helps organizations explain how Morpholinos can address research and therapeutic challenges and how customers can use these molecules.

Morpholinos are uncharged, steric-blocking antisense molecules that bind target sequences on RNA, preventing interactions with other large molecules. They can be used to block translation, modify splicing, or inhibit microRNAs. Widely used in embryos to investigate gene function during development, Morpholinos are also being explored for potential therapeutic applications. The site notes that four Morpholino drugs for Duchenne muscular dystrophy have been approved and that others are in clinical trials.

Services include RNA-targeting strategy and oligo sequence design, consultation on delivery to target cells, and training for technical support and marketing teams. Marketing assistance includes scientific writing, blog content, promotional materials, booth design, and conference representation.